Please enable JavaScript to continue using this application.

Compare $ATRA vs $RLYB | Chartloom

Compare

$ATRA vs $RLYB

Atara Biotherapeutics Inc · Rallybio Corp

ATRA

Atara Biotherapeutics Inc

RLYB

Rallybio Corp

Compare $ATRA vs $RLYB

Comparing Atara Biotherapeutics Inc and Rallybio Corp

ATRAAtara Biotherapeutics Inc

RLYBRallybio Corp

ATRAAtara Biotherapeutics Inc

Market cap

$85M

P/E (TTM)

—

Forward P/E (NTM)

14.78x

Forward P/S (NTM)

2.47x

Rev growth (TTM)

-96.7%

YTD performance

-46.7%

52W performance

-40.2%

FCF yield

-25.6%

RLYBRallybio Corp

Market cap

$90M

P/E (TTM)

2.17x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-15.1%

YTD performance

200.8%

52W performance

269.6%

FCF yield

29.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATRA

RLYB

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

RLYB

Rallybio Corp

Market Cap

ATRA$85M

RLYB$90M

Enterprise Value

ATRA$124M

RLYB$-3M

Price

ATRA$9.48

RLYB$17.02

P/E Ratio

ATRAN/A

RLYB2.17x

P/S Ratio

ATRA13.79x

RLYB139.64x

EV/Sales

ATRA19.98x

RLYB-4.09x

EV/EBITDA

ATRA3.51x

RLYB-0.10x

P/B Ratio

ATRA12.86x

RLYB0.96x

P/FCF Ratio

ATRAN/A

RLYB3.38x

EV/FCF

ATRA-5.65x

RLYB-0.10x

PEG Ratio

ATRAN/A

RLYBN/A

Forward P/E (NTM)

ATRA14.78x

RLYBN/A

Forward P/S (NTM)

ATRA2.47x

RLYBN/A

Revenue (TTM)

ATRA$6M

RLYB$646K

Revenue Growth (YoY)

ATRA-96.7%

RLYB-15.1%

Forward Rev Growth

ATRA1983.2%

RLYB499.1%

Gross Margin (TTM)

ATRA91.4%

RLYB0.0%

Operating Margin (TTM)

ATRA0.0%

RLYB0.0%

EBITDA Margin (TTM)

ATRA-194.7%

RLYB-4284.8%

Net Margin (TTM)

ATRA-269.4%

RLYB7051.2%

FCF Margin (TTM)

ATRA-353.5%

RLYB4135.0%

Net Income (TTM)

ATRA$-17M

RLYB$46M

FCF (TTM)

ATRA$-22M

RLYB$27M

EPS (TTM)

ATRA-$1.11

RLYB$7.86

ROE (TTM)

ATRA-31542.0%

RLYB68.6%

ROA (TTM)

ATRA-7301.0%

RLYB64.5%

ROIC (TTM)

ATRA-30684.0%

RLYB68.6%

Cash

ATRA$3M

RLYB$93M

Debt

ATRA$42M

RLYB$0

Net Cash/Debt

ATRA$-38M

RLYB$93M

Current Ratio (TTM)

ATRA1.98x

RLYB27.26x

Quick Ratio (TTM)

ATRA1.98x

RLYB27.01x

Debt/Equity (TTM)

ATRA0.12x

RLYB0.00x

Debt/Assets (TTM)

ATRA0.0%

RLYB0.0%

Interest Coverage (TTM)

ATRAN/A

RLYBN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

RLYB0.00x

Beta

ATRA0.31

RLYB-0.75

52W Performance

ATRA-40.2%

RLYB269.6%

YTD Performance

ATRA-46.7%

RLYB200.8%

% from 52W High

ATRA-50.5%

RLYB-3.2%

% from 52W Low

ATRA141.8%

RLYB363.7%

Asset Turnover (TTM)

ATRA0.27x

RLYB0.01x

FCF Yield (TTM)

ATRA-25.6%

RLYB29.6%

Earnings Yield (TTM)

ATRA-19.5%

RLYB50.5%

Dividend Yield (TTM)

ATRAN/A

RLYBN/A

Rule of 40

ATRA-450.2

RLYB4,119.9

EV/GP/RG

ATRA0.05

RLYBN/A

Ticker research

View ATRA research View RLYB research

Metric	ATRA Atara Biotherapeutics Inc	RLYB Rallybio Corp
Market & Valuation
Market Cap	$85M	$90M
Enterprise Value	$124M	$-3M
Price	$9.48	$17.02
P/E Ratio	N/A	2.17x
P/S Ratio	13.79x	139.64x
EV/Sales	19.98x	-4.09x
EV/EBITDA	3.51x	-0.10x
P/B Ratio	12.86x	0.96x
P/FCF Ratio	N/A	3.38x
EV/FCF	-5.65x	-0.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$646K
Revenue Growth (YoY)	-96.7%	-15.1%
Forward Rev Growth	1983.2%	499.1%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	-4284.8%
Net Margin (TTM)	-269.4%	7051.2%
FCF Margin (TTM)	-353.5%	4135.0%
Net Income (TTM)	$-17M	$46M
FCF (TTM)	$-22M	$27M
EPS (TTM)	-$1.11	$7.86
ROE (TTM)	-31542.0%	68.6%
ROA (TTM)	-7301.0%	64.5%
ROIC (TTM)	-30684.0%	68.6%
Financial Health
Cash	$3M	$93M
Debt	$42M	$0
Net Cash/Debt	$-38M	$93M
Current Ratio (TTM)	1.98x	27.26x
Quick Ratio (TTM)	1.98x	27.01x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	-0.75
52W Performance	-40.2%	269.6%
YTD Performance	-46.7%	200.8%
% from 52W High	-50.5%	-3.2%
% from 52W Low	141.8%	363.7%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.01x
FCF Yield (TTM)	-25.6%	29.6%
Earnings Yield (TTM)	-19.5%	50.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	4,119.9
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View RLYB research

Valuation

P/E Ratio

RLYB

2.17x

P/S Ratio

ATRA

13.79x

RLYB

139.64x

EV/FCF

ATRA

-5.65x

RLYB

-0.10x

Growth & revenue

Revenue Growth TTM

RLYB

-15.1%

ATRA

-96.7%

Forward Revenue Growth

ATRA

1983.2%

RLYB

499.1%

Profitability & performance

Gross Margin

ATRA

91.4%

RLYB

0.0%

ROE

RLYB

68.6%

ATRA

-31542.0%

FCF Yield %

RLYB

29.6%

ATRA

-25.6%

52-Week Performance

RLYB

269.6%

ATRA

-40.2%

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

RLYB

Rallybio Corp

Market Cap

ATRA$85M

RLYB$90M

Enterprise Value

ATRA$124M

RLYB$-3M

Price

ATRA$9.48

RLYB$17.02

P/E Ratio

ATRAN/A

RLYB2.17x

P/S Ratio

ATRA13.79x

RLYB139.64x

EV/Sales

ATRA19.98x

RLYB-4.09x

EV/EBITDA

ATRA3.51x

RLYB-0.10x

P/B Ratio

ATRA12.86x

RLYB0.96x

P/FCF Ratio

ATRAN/A

RLYB3.38x

EV/FCF

ATRA-5.65x

RLYB-0.10x

PEG Ratio

ATRAN/A

RLYBN/A

Forward P/E (NTM)

ATRA14.78x

RLYBN/A

Forward P/S (NTM)

ATRA2.47x

RLYBN/A

Revenue (TTM)

ATRA$6M

RLYB$646K

Revenue Growth (YoY)

ATRA-96.7%

RLYB-15.1%

Forward Rev Growth

ATRA1983.2%

RLYB499.1%

Gross Margin (TTM)

ATRA91.4%

RLYB0.0%

Operating Margin (TTM)

ATRA0.0%

RLYB0.0%

EBITDA Margin (TTM)

ATRA-194.7%

RLYB-4284.8%

Net Margin (TTM)

ATRA-269.4%

RLYB7051.2%

FCF Margin (TTM)

ATRA-353.5%

RLYB4135.0%

Net Income (TTM)

ATRA$-17M

RLYB$46M

FCF (TTM)

ATRA$-22M

RLYB$27M

EPS (TTM)

ATRA-$1.11

RLYB$7.86

ROE (TTM)

ATRA-31542.0%

RLYB68.6%

ROA (TTM)

ATRA-7301.0%

RLYB64.5%

ROIC (TTM)

ATRA-30684.0%

RLYB68.6%

Cash

ATRA$3M

RLYB$93M

Debt

ATRA$42M

RLYB$0

Net Cash/Debt

ATRA$-38M

RLYB$93M

Current Ratio (TTM)

ATRA1.98x

RLYB27.26x

Quick Ratio (TTM)

ATRA1.98x

RLYB27.01x

Debt/Equity (TTM)

ATRA0.12x

RLYB0.00x

Debt/Assets (TTM)

ATRA0.0%

RLYB0.0%

Interest Coverage (TTM)

ATRAN/A

RLYBN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

RLYB0.00x

Beta

ATRA0.31

RLYB-0.75

52W Performance

ATRA-40.2%

RLYB269.6%

YTD Performance

ATRA-46.7%

RLYB200.8%

% from 52W High

ATRA-50.5%

RLYB-3.2%

% from 52W Low

ATRA141.8%

RLYB363.7%

Asset Turnover (TTM)

ATRA0.27x

RLYB0.01x

FCF Yield (TTM)

ATRA-25.6%

RLYB29.6%

Earnings Yield (TTM)

ATRA-19.5%

RLYB50.5%

Dividend Yield (TTM)

ATRAN/A

RLYBN/A

Rule of 40

ATRA-450.2

RLYB4,119.9

EV/GP/RG

ATRA0.05

RLYBN/A

Ticker research

View ATRA research View RLYB research

Metric	ATRA Atara Biotherapeutics Inc	RLYB Rallybio Corp
Market & Valuation
Market Cap	$85M	$90M
Enterprise Value	$124M	$-3M
Price	$9.48	$17.02
P/E Ratio	N/A	2.17x
P/S Ratio	13.79x	139.64x
EV/Sales	19.98x	-4.09x
EV/EBITDA	3.51x	-0.10x
P/B Ratio	12.86x	0.96x
P/FCF Ratio	N/A	3.38x
EV/FCF	-5.65x	-0.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$646K
Revenue Growth (YoY)	-96.7%	-15.1%
Forward Rev Growth	1983.2%	499.1%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	-4284.8%
Net Margin (TTM)	-269.4%	7051.2%
FCF Margin (TTM)	-353.5%	4135.0%
Net Income (TTM)	$-17M	$46M
FCF (TTM)	$-22M	$27M
EPS (TTM)	-$1.11	$7.86
ROE (TTM)	-31542.0%	68.6%
ROA (TTM)	-7301.0%	64.5%
ROIC (TTM)	-30684.0%	68.6%
Financial Health
Cash	$3M	$93M
Debt	$42M	$0
Net Cash/Debt	$-38M	$93M
Current Ratio (TTM)	1.98x	27.26x
Quick Ratio (TTM)	1.98x	27.01x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	-0.75
52W Performance	-40.2%	269.6%
YTD Performance	-46.7%	200.8%
% from 52W High	-50.5%	-3.2%
% from 52W Low	141.8%	363.7%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.01x
FCF Yield (TTM)	-25.6%	29.6%
Earnings Yield (TTM)	-19.5%	50.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	4,119.9
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View RLYB research